Louisa Edwards

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Journal: Pharmacogenomics

Published: June 15, 2026

Characterizing models for delivery of pharmacogenomic testing: a scoping review.

Characterizing models for delivery of pharmacogenomic testing: a scoping review.

Journal: Pharmacogenomics

Published: October 14, 2025

Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation.

Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation.

Journal: Journal of affective disorders

Published: October 14, 2025

Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohort.

Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohort.

Journal: BMJ open

Published: January 14, 2025

Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.

Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: July 26, 2024

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.

Journal: PharmacoEconomics - open

Published: February 25, 2024

Cost-effectiveness of pharmacogenomic-guided treatment for major depression.

Cost-effectiveness of pharmacogenomic-guided treatment for major depression.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: September 18, 2023

Costs of major depression covered / not covered in British Columbia, Canada.

Costs of major depression covered / not covered in British Columbia, Canada.

Journal: BMC health services research

Published: April 29, 2023

Co-learning commentary: a patient partner perspective in mental health care research.

Co-learning commentary: a patient partner perspective in mental health care research.

Journal: Research involvement and engagement

Published: February 14, 2023

Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.

Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: November 28, 2022

Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online public deliberation.

Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online public deliberation.

Journal: BMC public health

Published: November 26, 2022

Adding epitope compatibility to deceased donor kidney allocation criteria: recommendations from a pan-Canadian online public deliberation.

Adding epitope compatibility to deceased donor kidney allocation criteria: recommendations from a pan-Canadian online public deliberation.

Journal: BMC nephrology

Published: November 10, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026